Medical Devices industry cross border M&A deals total $1.5bn globally in Q3 2022

Total medical devices industry cross border M&A deals worth $1.5bn were announced globally in Q3 2022, led by Azenta’s $468.22m acquisition of B Medical Systems, according to GlobalData’s deals database.

The value marked a decrease of 46.4% over the previous quarter of $2.78bn and a drop of 70.8% when compared with the last four-quarter average, which stood at $5.1bn.

Comparing cross border M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $1.05bn. At the country level, the Luxembourg topped the list in terms of deal value at $468.22m.

In terms of volumes, Europe emerged as the top region for medical devices industry cross border M&A deals globally, followed by North America and then Asia-Pacific.

The top country in terms of cross border M&A deals activity in Q3 2022 was the US with 12 deals, followed by Germany with five and the UK with four.

In 2022, at the end of , cross border M&A deals worth $5.82bn were announced globally in medical devices industry, marking an increase of 68.7% year on year.

Cross Border M&A deals in medical devices industry in Q3 2022: Top deals

The top five cross border M&A deals in medical devices industry accounted for 68.7% of the overall value during Q3 2022.

The combined value of the top deals stood at $1.21bn, against the overall value of $1.5bn recorded for the quarter.

The top five medical devices industry cross border medical devices deals of Q3 2022 tracked by GlobalData were:

1) Azenta’s $468.22m acquisition deal with B Medical Systems

2) The $243.32m acquisition of Medi-Globe by DCC Healthcare

3) The $176m merger deal with NewSight Imaging and Vision Sensing Acquisition

4) The $170m acquisition of Curiosity Diagnostics by Bio-Rad Laboratories

5) Halma’s $154.02m acquisition deal with IZI Medical Products